Used as an intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of pharmaceutical compounds. Its boronate ester group enables efficient carbon-carbon bond formation, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders and inflammatory diseases. The amine functionality allows for further derivatization, making it valuable in medicinal chemistry for building complex drug-like molecules. Commonly employed in late-stage functionalization due to its stability and reactivity profile.